Larvol Delta - Citius-announces-PreIND-submission-to-FDA-under-the-coronavirus-treatment-acceleration-program-for-a-novel-stem-cell-therapy-for-Acute-Respiratory-Distress-Syndrome-ARDS-in-Covid19

mesenchymal stem cell therapy - Citius, Brooklyn ImmunoTherap

https://www.prnewswire.com/news-releases/citius-announces-pre-ind-submission-to-fda-under-the-coronavirus-treatment-acceleration-program-for-a-novel-stem-cell-therapy-for-acute-respiratory-distress-syndrome-ards-in-covid-19-301047150.html

Apr 27, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev